Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (43)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Deybach, J. C.
Right arrow Articles by Nordmann, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deybach, J. C.
Right arrow Articles by Nordmann, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 5, 407-410, Copyright © 1996 by Oxford University Press


ARTICLES

Mutations in the protoporphyrinogen oxidase gene in patients with variegate porphyria

JC Deybach, H Puy, AM Robreau, J Lamoril, V Da Silva, B Grandchamp and Y Nordmann
Centre Francais des Porphyries, INSERM U409, Hopital Louis Mourier, Colombes, France.

Variegate porphyria (VP) is an acute hepatic porphyria with autosomal dominant inheritance due to a partial deficiency of protoporphyrinogen oxidase (PPOX) activity. The molecular defect responsible for VP was investigated by sequencing PPOX gene coding sequence from four patients in three unrelated VP families of French Caucasian origin. In a first patient, a point insertion of a G at position 1022 of the cDNA, produced a frameshift resulting in a premature stop codon. In three other patients from two unrelated families we found a missense point mutation leading to glycine to arginine substitution (G232R) in exon 7. This Gly232 appears to be a strictly conserved residue through evolution. In one VP family, we observed the cosegregation of the G232R missense mutation and the deficient PPOX activity. The mutations reported here are the first to be described in patients with VP and support the conclusion that PPOX gene defects are disease causing mutations in human variegate porphyria.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Annals of Clinical & Laboratory ScienceHome page
J. G. Donnelly, S. Detombe, and J. T. Hindmarsh
Single-Strand Conformational Polymorphism and Denaturing Gradient Gel Electrophoresis in Screening for Variegate Porphyria: Identification of Two New Mutations
Ann. Clin. Lab. Sci., April 1, 2002; 32(2): 107 - 113.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. Christiansen, A. Bygum, M. Kaehne, A. Jensen, M. Horder, and N. E. Petersen
Mutation Screening of the Entire Coding Region of the Protoporphyrinogen Oxidase Gene Using Denaturing Gradient Gel Electrophoresis and Denaturing HPLC
Clin. Chem., June 1, 2001; 47(6): 1115 - 1117.
[Full Text] [PDF]


Home page
Alcohol AlcoholHome page
M. O. Doss, A. Kuhnel, and U. Gross
ALCOHOL AND PORPHYRIN METABOLISM
Alcohol Alcohol., March 1, 2000; 35(2): 109 - 125.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.